Discharge outcomes of intravenous alteplase 4.5-24 hours after symptom onset in selected patients with acute ischemic stroke: a propensity score-matched real-world study. [PDF]
Meng L +7 more
europepmc +1 more source
A Bayesian conditional probability simulation framework for pre-hospital stroke transport decisions in the tenecteplase era: decision boundaries, global sensitivity, and stochastic dominance. [PDF]
Çalışır T.
europepmc +1 more source
Tenecteplase in acute ischemic stroke: an updated meta-analysis. [PDF]
Almohammed H +8 more
europepmc +1 more source
The evaluation of Tenecteplase for the treatment of ischemic stroke (real-world data). [PDF]
Braun W +8 more
europepmc +1 more source
Intrapleural Fibrinolytic Therapy in the Management of Pediatric Pleural Empyema: A Narrative Review. [PDF]
Esposito S +3 more
europepmc +1 more source
Clinical outcomes and bleeding events associated with tirofiban combined with intravenous alteplase in acute ischaemic stroke: a retrospective single-center study. [PDF]
Pang H, Sui H, Fu C.
europepmc +1 more source
Trends in Thrombolysis in Stroke (2015-2024). [PDF]
Wright DS +6 more
europepmc +1 more source
Optimal Duration of Ultrasound-Facilitated Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: A Retrospective Cohort Study. [PDF]
Lin YK +8 more
europepmc +1 more source
Trade-Off Between Early Reperfusion and First-Pass Effect With Tenecteplase Versus Alteplase Before Stroke Thrombectomy. [PDF]
Bielinski TM +9 more
europepmc +1 more source
Imaging patterns of hemorrhagic transformation after tenecteplase versus alteplase in real-world practice. [PDF]
Guo S +5 more
europepmc +1 more source

